About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Potential Drug Target Discovered for Rare Genetic Disease

by Bidita Debnath on November 17, 2013 at 11:04 PM
Font : A-A+

 Potential Drug Target Discovered for Rare Genetic Disease

At the University of Alberta, medical researchers have discovered the structure of a potential drug target for a rare genetic disease, paving the way for an alternative treatment for the condition.

Faculty of Medicine & Dentistry researcher Michael James and his team recently published their findings about MPS I (Mucopolysaccharidosis I) in the peer-reviewed journal, Nature Chemical Biology.

Advertisement

Children born with a severe form of this disease usually die before they are 10 years old, while those with less severe forms can live well into adulthood. Symptoms can include improperly formed bones and teeth, carpal tunnel syndrome, an enlarged spleen, hearing or vision problems, distinct facial characteristics, heart problems and mental delays.

MPS I affects about one in 100,000 people. The human body continually churns out building blocks that rebuild various parts of the body, such as bone and cartilage. For example, bones in the body are rebuilt every seven years. "Your body has to have a way of doing this, so that there is a breakdown of bone and then a production of the bone building-blocks," said research associate and team member Jiang Yin. He explained that with MPS I, the body can't complete this process due to a malfunctioning enzyme.
Advertisement

The gene responsible for creating this enzyme and directing its work is mutated in patients who have the disease. In fact, more than 100 mutations in this gene can cause the disease and impact its severity. In order to better understand MPS I, researchers have been trying to figure out the three-dimensional structure of this important enzyme.

James's team was the first to determine the 3-D structures that link specific defects in the enzyme to specific symptoms of the disease and specific genetic mutations. "Now that we know how this enzyme functions and where the mutations are, the sites of the mutations can now be related to the disease symptoms" said James. "We've identified a drug target. There won't be a cure yet, but hopefully we can develop drugs to treat the less severe forms of the disease."

Yin added: "If we can treat people in the early stages of the disease, we may be able to lessen the severity of the disease and the mental delays." James said this paves the way for the possibility of an alternative to enzyme replacement therapy, which involves weekly injections of a needle between a protective membrane and the spinal cord. The treatment is both painful and expensive, costing about $450,000 a year per patient.The U of A team has been collaborating with researchers from Simon Fraser University and the University of British Columbia on their work. Haiying Bie, a post-doctoral fellow from the U of A, was also a key member of the team. "We're very excited about this discovery," said James.

"We've all worked very hard."Approximately 70 diseases relate to improperly functioning enzymes and collectively affect 1 in 5,000 people around the world. These diseases are caused by a deficiency in the lysosomal enzymes responsible for breaking down large molecules in the body - such as those that make up bones, cartilage or fat.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
Goji Berries May Protect Against Age-Related Vision Loss
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Genetics and Stem Cells Signature Drug Toxicity Pompe Disease Farber disease Usher Syndrome Prader-Willi Syndrome Christianson Syndrome 

Recommended Reading
Genetic Disease Which Causes Recurrent Respiratory Infections Discovered
A rare genetic disease which predisposes patients to severe respiratory infections and lung damage ....
Idea of an Italian Scientist to Use HIV to Cure 2 Genetic Diseases Proves Successful
New research has indicated that the AIDS virus can be used to treat two severe hereditary diseases....
Researchers Question Effectiveness of Drug PTC124/Ataluren Used in Treating Genetic Diseases
Researchers have cast doubt on the mechanistic basis of a drug known as PTC124 (or Ataluren), used ....
Additional Specialists, Improved Networking Among Doctors Key for India to Combat Rare Genetic Disease
Childcare experts in India have revealed that the country needs to improve its networking among ......
Christianson Syndrome
Christianson syndrome is a condition that occurs due to mutations (abnormal changes) in the gene SLC...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Farber disease
Farber disease is a genetic disease characterised by the deficiency of ceramidase. It has no specifi...
Pompe Disease
Pompe disease or Glycogen Storage Disease is a rare genetic disease caused by the buildup of a sugar...
Prader-Willi Syndrome
Prader-Willi Syndrome (PWS) is a rare genetic disorder affecting multiple body systems. Prader-Willi...
Usher Syndrome
Usher syndrome is a rare genetic disease which is the leading cause of deaf-blindness in humans....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)